Edap Tms (NASDAQ:EDAP) Cut to “Sell” at StockNews.com

StockNews.com lowered shares of Edap Tms (NASDAQ:EDAP) from a hold rating to a sell rating in a report published on Tuesday.

Separately, HC Wainwright reissued a “buy” rating and set a $19.00 target price on shares of Edap Tms in a research report on Thursday, August 29th.

Edap Tms Price Performance

Edap Tms stock opened at $2.41 on Tuesday. Edap Tms has a 52 week low of $2.27 and a 52 week high of $8.50. The company’s 50 day moving average price is $2.67 and its two-hundred day moving average price is $4.06. The company has a quick ratio of 1.46, a current ratio of 2.18 and a debt-to-equity ratio of 0.08. The stock has a market cap of $89.41 million, a P/E ratio of -3.71 and a beta of 0.38.

Edap Tms (NASDAQ:EDAP) last posted its earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.04). Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The firm had revenue of $16.97 million for the quarter, compared to the consensus estimate of $17.16 million. On average, equities analysts predict that Edap Tms will post -0.6 earnings per share for the current year.

Institutional Investors Weigh In On Edap Tms

A number of hedge funds have recently modified their holdings of EDAP. Virtu Financial LLC bought a new stake in shares of Edap Tms in the 1st quarter worth approximately $82,000. Commonwealth Equity Services LLC grew its stake in Edap Tms by 5.9% in the 2nd quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock valued at $388,000 after buying an additional 4,000 shares in the last quarter. Redhawk Wealth Advisors Inc. purchased a new position in Edap Tms in the 3rd quarter valued at approximately $36,000. BNP Paribas Financial Markets grew its stake in Edap Tms by 23.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after buying an additional 4,400 shares in the last quarter. Finally, Parkman Healthcare Partners LLC purchased a new position in Edap Tms in the 3rd quarter valued at approximately $395,000. Institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.